Literature DB >> 17346200

Epigenetic alterations of the Wnt/beta-catenin pathway in human disease.

Oscar Aguilera1, Alberto Muñoz, Manel Esteller, Mario F Fraga.   

Abstract

The Wnt/beta-catenin pathway plays critical roles in cell physiology, including determination, proliferation, migration and differentiation in embryonic development and adult homeostasis. Several components of the Wnt/beta-catenin pathway, such as SFRPs, WIF-1, DKK-1, APC, AXIN2, ICAT, LEF1 and beta-catenin, are the target of mutations or epigenetic inactivation leading to the deregulation or constitutive activation of the Wnt/beta-catenin pathway. Aberrant activation of the Wnt signalling pathway abrogates controlled growth and impairs cell differentiation. Alterations of the Wnt signalling pathway have been found in cancer, osteoporosis, ischemic neuronal death and other human diseases. Here we review the alterations of the Wnt/beta-catenin signalling cascade and discuss the biological significance and relationship between mutation and/or epigenetic silencing within the same pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346200     DOI: 10.2174/187153007780059450

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  17 in total

1.  Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide.

Authors:  Chad C Bjorklund; Wencai Ma; Zhi-Qiang Wang; R Eric Davis; Deborah J Kuhn; Steven M Kornblau; Michael Wang; Jatin J Shah; Robert Z Orlowski
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

Review 2.  The complex roles of Wnt antagonists in RCC.

Authors:  Sharanjot Saini; Shahana Majid; Rajvir Dahiya
Journal:  Nat Rev Urol       Date:  2011-10-25       Impact factor: 14.432

3.  Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer.

Authors:  Ester Lara; Vincenzo Calvanese; Covadonga Huidobro; Agustin F Fernández; Angela Moncada-Pazos; Alvaro J Obaya; Oscar Aguilera; José Manuel González-Sancho; Laura Sánchez; Aurora Astudillo; Alberto Muñoz; Carlos López-Otín; Manel Esteller; Mario F Fraga
Journal:  Mol Cancer       Date:  2010-06-30       Impact factor: 27.401

Review 4.  Wnt signalling and cancer stem cells.

Authors:  Jesús Espada; Moisés B Calvo; Silvia Díaz-Prado; Vanessa Medina
Journal:  Clin Transl Oncol       Date:  2009-07       Impact factor: 3.405

5.  HuR and TTP: two RNA binding proteins that deliver message from the 3' end.

Authors:  Shrikant Anant; Courtney W Houchen
Journal:  Gastroenterology       Date:  2009-03-25       Impact factor: 22.682

6.  Epigenetic modulation of signal transduction pathways in HPV-associated HNSCC.

Authors:  Maria J Worsham; Kang Mei Chen; Tamer Ghanem; Josena K Stephen; George Divine
Journal:  Otolaryngol Head Neck Surg       Date:  2013-06-04       Impact factor: 3.497

Review 7.  Epigenetic gene silencing in the Wnt pathway in breast cancer.

Authors:  George J Klarmann; Amy Decker; William L Farrar
Journal:  Epigenetics       Date:  2008-03-12       Impact factor: 4.528

8.  Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer.

Authors:  Jürgen Veeck; Peter J Wild; Thomas Fuchs; Peter J Schüffler; Arndt Hartmann; Ruth Knüchel; Edgar Dahl
Journal:  BMC Cancer       Date:  2009-07-01       Impact factor: 4.430

9.  High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Jianfei Huang; Xiangjun Fan; Xudong Wang; Yuhua Lu; Huijun Zhu; Wei Wang; Shu Zhang; Zhiwei Wang
Journal:  Sci Rep       Date:  2015-08-11       Impact factor: 4.379

10.  Beta-catenin and epithelial tumors: a study based on 374 oropharyngeal cancers.

Authors:  Angela Santoro; Giuseppe Pannone; Silvana Papagerakis; H Stan McGuff; Barbara Cafarelli; Silvia Lepore; Salvatore De Maria; Corrado Rubini; Marilena Mattoni; Stefania Staibano; Ernesto Mezza; Gaetano De Rosa; Gabriella Aquino; Simona Losito; Carla Loreto; Salvatore Crimi; Pantaleo Bufo; Lorenzo Lo Muzio
Journal:  Biomed Res Int       Date:  2014-01-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.